Evidence map›Paper›PMID 32601062›Full record

ArticleThe Journal of biological chemistry2020

PelX is a UDP-

Lindsey S Marmont, Gregory B Whitfield, Roland Pfoh, Rohan J Williams, Trevor E Randall, Alexandra Ostaszewski, Erum Razvi, Ryan A Groves, Howard Robinson, Mark Nitz and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Lindsey S MarmontProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Gregory B WhitfieldProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Roland PfohProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Rohan J WilliamsDepartment of Chemistry, University of Toronto, Toronto, Ontario, Canada.
Trevor E RandallDepartment of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Alexandra OstaszewskiDepartment of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Erum RazviProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Ryan A GrovesDepartment of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Howard RobinsonPhoton Science Division, Brookhaven National Laboratory, Upton, New York, USA.
Mark NitzDepartment of Chemistry, University of Toronto, Toronto, Ontario, Canada.
Matthew R ParsekDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Ian A LewisDepartment of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
John C WhitneyProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Joe J HarrisonDepartment of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
P Lynne HowellProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada. Electronic address: howell@sickkids.ca.
University of Toronto · CAUniversity of Calgary · CABrookhaven National Laboratory · USHospital for Sick Children · CAUniversity of Washington · US

Funding

Case Center for Synchrotron BiosciencesP30EB009998 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI CHANCE, MARK R · 2009 to 2018
$8.4M
The pel exopolysaccharide gene cluster of Pseudomonas aeruginosaR01AI077628 · NIAID · UNIVERSITY OF WASHINGTON · PI MATTHEW R. PARSEK, Daniel J Wozniak · 2009 to 2026
$7.1M
The biofilm matrix of P. aeruginosaR01AI143916 · NIAID · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL, PARSEK, MATTHEW R. · 2019 to 2023
$2.9M
Revisiting alginate paradigmsR01AI134895 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2018 to 2022
$2.5M
CIHR FDN154327CIHR MOP 43998NIAID NIH HHS R01 AI077628NIAID NIH HHS R01 AI134895NIAID NIH HHS R01 AI143916NIBIB NIH HHS P30 EB009998
6 · The paper itself

Abstract

Pel is a GalNAc-rich bacterial polysaccharide that contributes to the structure and function of

Indexed as

BiofilmsBacterial ProteinsCarbohydrate EpimerasesPolysaccharides, BacterialPseudomonasPseudomonas aeruginosaUridine Diphosphate N-AcetylglucosamineBacterial ProteinsCarbohydrate EpimerasesPolysaccharides, BacterialUridine Diphosphate N-Acetylglucosaminebacterial adhesionbiofilmenzymeepimerasemicrobiologyPelXPgnEpolysaccharidePseudomonasPseudomonas aeruginosaPseudomonas protegensshort-chain dehydrogenase/reductaseX-ray crystallography

Identifiers

PMID32601062
PMCPMC7443510
OpenAlexW3039382986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.